Themis Medicare Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Themis Medicare.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 18.8% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
What Themis Medicare Limited's (NSE:THEMISMED) 42% Share Price Gain Is Not Telling You
Dec 27
Themis Medicare (NSE:THEMISMED) Takes On Some Risk With Its Use Of Debt
Dec 01Themis Medicare (NSE:THEMISMED) Has Affirmed Its Dividend Of ₹5.00
Aug 18Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Aug 04Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Jul 18We Think Themis Medicare (NSE:THEMISMED) Is Taking Some Risk With Its Debt
Jul 08Themis Medicare (NSE:THEMISMED) Is Due To Pay A Dividend Of ₹5.00
May 18Themis Medicare (NSE:THEMISMED) Seems To Use Debt Quite Sensibly
Dec 21Themis Medicare (NSE:THEMISMED) Has Announced That It Will Be Increasing Its Dividend To ₹5.00
Aug 28Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹5.00
Aug 08Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
Jul 21Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
May 27Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
May 12Calculating The Fair Value Of Themis Medicare Limited (NSE:THEMISMED)
Nov 09Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
Oct 26Increases to Themis Medicare Limited's (NSE:THEMISMED) CEO Compensation Might Cool off for now
Sep 11Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹4.30
Aug 16Do Themis Medicare's (NSE:THEMISMED) Earnings Warrant Your Attention?
Jul 09Estimating The Intrinsic Value Of Themis Medicare Limited (NSE:THEMISMED)
May 14If You Like EPS Growth Then Check Out Themis Medicare (NSE:THEMISMED) Before It's Too Late
Mar 23These 4 Measures Indicate That Themis Medicare (NSE:THEMISMED) Is Using Debt Reasonably Well
Mar 02Why Themis Medicare Limited (NSE:THEMISMED) Is A Top Dividend Stock
Feb 08Themis Medicare Limited's (NSE:THEMISMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 11
Here's What We Think About Themis Medicare's (NSE:THEMISMED) CEO Pay
Dec 14Does Themis Medicare (NSE:THEMISMED) Have A Healthy Balance Sheet?
Nov 16Are You An Income Investor? Don't Miss Out On Themis Medicare Limited (NSE:THEMISMED)
Oct 21Themis Medicare Limited (NSE:THEMISMED) Looks Interesting, And It's About To Pay A Dividend
Sep 13In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Themis Medicare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 3,640 | 453 | N/A | N/A | N/A |
| 9/30/2023 | 3,703 | 512 | -89 | 179 | N/A |
| 6/30/2023 | 3,565 | 577 | N/A | N/A | N/A |
| 3/31/2023 | 3,543 | 569 | -127 | 161 | N/A |
| 12/31/2022 | 3,540 | 584 | N/A | N/A | N/A |
| 9/30/2022 | 3,602 | 576 | -72 | 180 | N/A |
| 6/30/2022 | 3,765 | 591 | N/A | N/A | N/A |
| 3/31/2022 | 3,946 | 729 | 138 | 344 | N/A |
| 12/31/2021 | 3,766 | 710 | N/A | N/A | N/A |
| 9/30/2021 | 3,472 | 703 | 395 | 570 | N/A |
| 6/30/2021 | 2,947 | 591 | N/A | N/A | N/A |
| 3/31/2021 | 2,307 | 357 | 389 | 570 | N/A |
| 12/31/2020 | 2,151 | 349 | N/A | N/A | N/A |
| 9/30/2020 | 2,033 | 338 | 131 | 263 | N/A |
| 6/30/2020 | 1,987 | 274 | N/A | N/A | N/A |
| 3/31/2020 | 2,016 | 248 | -55 | 3 | N/A |
| 12/31/2019 | 1,911 | 61 | N/A | N/A | N/A |
| 9/30/2019 | 1,855 | -45 | 99 | 124 | N/A |
| 6/30/2019 | 1,846 | -64 | N/A | N/A | N/A |
| 3/31/2019 | 1,838 | -107 | 53 | 109 | N/A |
| 12/31/2018 | 2,002 | 54 | N/A | N/A | N/A |
| 9/30/2018 | 2,022 | 78 | N/A | N/A | N/A |
| 6/30/2018 | 2,063 | 101 | N/A | N/A | N/A |
| 3/31/2018 | 2,095 | 113 | -17 | 79 | N/A |
| 12/31/2017 | 2,354 | 105 | N/A | N/A | N/A |
| 9/30/2017 | 2,399 | 143 | N/A | N/A | N/A |
| 6/30/2017 | 2,323 | 142 | N/A | N/A | N/A |
| 3/31/2017 | 2,167 | 160 | N/A | -15 | N/A |
| 12/31/2016 | 2,438 | 211 | N/A | N/A | N/A |
| 9/30/2016 | 2,368 | 212 | N/A | N/A | N/A |
| 6/30/2016 | 2,404 | 208 | N/A | N/A | N/A |
| 3/31/2016 | 2,324 | 163 | N/A | 258 | N/A |
| 12/31/2015 | 2,287 | 155 | N/A | N/A | N/A |
| 9/30/2015 | 2,227 | 142 | N/A | N/A | N/A |
| 6/30/2015 | 2,022 | 71 | N/A | N/A | N/A |
| 3/31/2015 | 2,019 | 62 | N/A | 191 | N/A |
| 3/31/2014 | 1,951 | 27 | N/A | 83 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if THEMISMED's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if THEMISMED's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if THEMISMED's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if THEMISMED's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if THEMISMED's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if THEMISMED's Return on Equity is forecast to be high in 3 years time